2021
DOI: 10.3389/fmed.2021.817884
|View full text |Cite
|
Sign up to set email alerts
|

Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?

Abstract: Non-steroidal anti-inflammatory drugs (NSAIDs) remain the mainstay of treatment for spondyloarthritides (SpA), a group of entities with common clinical and pathophysiological aspects, but also with differential features. Although NSAIDs provide significant symptomatic relief, especially for joint pain and morning stiffness, their role in achieving and maintaining the treatment goals advocated by the treat to target strategy in SpA is not entirely clear. These agents can induce changes in the composition of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…This may be due to the continuous stimulation of the immune system by intestinal antigens, probably related to dysbiosis. It is possible that the condition of intestinal damage and disturbance of the microbiome itself is linked to NSAID use [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This may be due to the continuous stimulation of the immune system by intestinal antigens, probably related to dysbiosis. It is possible that the condition of intestinal damage and disturbance of the microbiome itself is linked to NSAID use [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…This may be due to the continuous stimulation of the immune system by intestinal antigens, probably related to dysbiosis. It is possible that the condition of intestinal damage and disturbance of the microbiome itself is linked to NSAID use [37]. This is a very exciting result, especially in the context of the study showing that the use of the zonulin antagonist larazotide acetate can inhibit arthritis [36].…”
Section: Discussionmentioning
confidence: 99%
“…For SpA patients, NSAIDs can effectively alleviate the symptoms of SpA, such as morning stiffness and joint pain ( Queiro-Silva et al., 2021 ). Even so, different NSAID treatments can cause a distinct alteration in the bacterial composition, which contributes to intestinal damage during NSAID treatment ( Rogers and Aronoff, 2016 ; Otani et al., 2017 ).…”
Section: Spa Therapeutic Medication and Gut Microbiomementioning
confidence: 99%